XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
2021 Agent Equity Program
2022 Agent Equity Program
Common Stock
Common Stock
2021 Agent Equity Program
Common Stock
2022 Agent Equity Program
Additional Paid-in Capital
Additional Paid-in Capital
2021 Agent Equity Program
Additional Paid-in Capital
2022 Agent Equity Program
Accumulated Deficit
Total Compass, Inc. Stockholders’ Equity
Total Compass, Inc. Stockholders’ Equity
2021 Agent Equity Program
Total Compass, Inc. Stockholders’ Equity
2022 Agent Equity Program
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2021       409,267,751                    
Beginning balance at Dec. 31, 2021 $ 847.6           $ 2,438.8     $ (1,595.0) $ 843.8     $ 3.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (443.5)                 (443.4) (443.4)     (0.1)
Issuance of common stock in connection with acquisitions (in shares)       335,252                    
Issuance of common stock in connection with acquisitions 2.0           2.0       2.0      
Issuance of common stock upon exercise of stock options (in shares)       3,949,244                    
Issuance of common stock upon exercise of stock options 8.6           8.6       8.6      
Issuance of common stock upon settlement of RSUs, net of taxes withheld (in shares)       6,328,555                    
Issuance of common stock upon settlement of RSUs, net of taxes withheld (19.5)           (19.5)       (19.5)      
Vesting of early exercised stock options 5.3           5.3       5.3      
Issuance of common stock in connection with the Agent Equity Program (in shares)         13,608,896                  
Issuance of common stock in connection with the Agent Equity Program   $ 100.0           $ 100.0       $ 100.0    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       578,921                    
Issuance of common stock under the Employee Stock Purchase Plan 2.3           2.3       2.3      
Stock-based compensation 138.8           138.8       138.8      
Ending balance (in shares) at Sep. 30, 2022       434,068,619                    
Ending balance at Sep. 30, 2022 641.6           2,676.3     (2,038.4) 637.9     3.7
Beginning balance (in shares) at Jun. 30, 2022       429,957,017                    
Beginning balance at Jun. 30, 2022 755.8           2,636.4     (1,884.2) 752.2     3.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (154.1)                 (154.2) (154.2)     0.1
Issuance of common stock in connection with acquisitions (in shares)       211,400                    
Issuance of common stock in connection with acquisitions 1.2           1.2       1.2      
Issuance of common stock upon exercise of stock options (in shares)       417,056                    
Issuance of common stock upon exercise of stock options 0.9           0.9       0.9      
Issuance of common stock upon settlement of RSUs, net of taxes withheld (in shares)       2,904,225                    
Issuance of common stock upon settlement of RSUs, net of taxes withheld (5.7)           (5.7)       (5.7)      
Vesting of early exercised stock options 3.1           3.1       3.1      
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       578,921                    
Issuance of common stock under the Employee Stock Purchase Plan 2.3           2.3       2.3      
Stock-based compensation 38.1           38.1       38.1      
Ending balance (in shares) at Sep. 30, 2022       434,068,619                    
Ending balance at Sep. 30, 2022 $ 641.6           2,676.3     (2,038.4) 637.9     3.7
Beginning balance (in shares) at Dec. 31, 2022 438,098,194     438,098,194                    
Beginning balance at Dec. 31, 2022 $ 520.7           2,713.6     (2,196.5) 517.1     3.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (236.3)                 (237.6) (237.6)     1.3
Issuance of common stock in connection with acquisitions (in shares)       3,215,610                    
Issuance of common stock in connection with acquisitions $ 10.6           10.6       10.6      
Issuance of common stock upon exercise of stock options (in shares) 2,745,170     2,745,170                    
Issuance of common stock upon exercise of stock options $ 4.2           4.2       4.2      
Issuance of common stock upon settlement of RSUs, net of taxes withheld (in shares)       9,919,619                    
Issuance of common stock upon settlement of RSUs, net of taxes withheld (17.9)           (17.9)       (17.9)      
Vesting of early exercised stock options 0.4           0.4       0.4      
Issuance of common stock in connection with the Agent Equity Program (in shares)           14,147,480                
Issuance of common stock in connection with the Agent Equity Program     $ 53.3           $ 53.3       $ 53.3  
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       759,835                    
Issuance of common stock under the Employee Stock Purchase Plan 2.5           2.5       2.5      
Issuance of common stock in connection with the Strategic Transaction (in shares)       8,957,910                    
Issuance of common stock in connection with the Strategic Transaction 30.0           30.0       30.0      
Stock-based compensation 111.4           111.4       111.4      
Other activity related to non-controlling interests $ (1.5)                         (1.5)
Ending balance (in shares) at Sep. 30, 2023 477,843,818     477,843,818                    
Ending balance at Sep. 30, 2023 $ 477.4           2,908.1     (2,434.1) 474.0     3.4
Beginning balance (in shares) at Jun. 30, 2023       462,987,617                    
Beginning balance at Jun. 30, 2023 451.7           2,842.3     (2,394.7) 447.6     4.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (39.2)                 (39.4) (39.4)     0.2
Issuance of common stock in connection with acquisitions (in shares)       637,406                    
Issuance of common stock in connection with acquisitions 2.4           2.4       2.4      
Issuance of common stock upon exercise of stock options (in shares)       648,062                    
Issuance of common stock upon exercise of stock options 1.3           1.3       1.3      
Issuance of common stock upon settlement of RSUs, net of taxes withheld (in shares)       4,221,908                    
Issuance of common stock upon settlement of RSUs, net of taxes withheld (7.6)           (7.6)       (7.6)      
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       390,915                    
Issuance of common stock under the Employee Stock Purchase Plan 1.1           1.1       1.1      
Issuance of common stock in connection with the Strategic Transaction (in shares)       8,957,910                    
Issuance of common stock in connection with the Strategic Transaction 30.0           30.0       30.0      
Stock-based compensation 38.6           38.6       38.6      
Other activity related to non-controlling interests $ (0.9)                         (0.9)
Ending balance (in shares) at Sep. 30, 2023 477,843,818     477,843,818                    
Ending balance at Sep. 30, 2023 $ 477.4           $ 2,908.1     $ (2,434.1) $ 474.0     $ 3.4